The purpose of this trial is to evaluate the efficacy of combined behavioral and
pharmacological treatment on chronic daily headache in children ages 10 to 17.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination